GILEAD SCIENCES, INC. Deferred Tax Liabilities, Property, Plant and Equipment
GILEAD SCIENCES, INC. (GILD) had Deferred Tax Liabilities, Property, Plant and Equipment of $288.00 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2026-02-24
- 2025-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $288.00M.
- 2024-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $276.00M.
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $274.00M.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $234.00M.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment |
|---|---|
| 2025-12-31 | $288.00M 10-K · filed 2026-02-24 |
| 2024-12-31 | $276.00M 10-K · filed 2026-02-24 |
| 2023-12-31 | $274.00M 10-K · filed 2025-02-28 |
| 2022-12-31 | $234.00M 10-K · filed 2024-02-23 |
| 2021-12-31 | $227.00M 10-K · filed 2023-02-22 |
| 2020-12-31 | $202.00M 10-K · filed 2022-02-23 |
| 2019-12-31 | $88.00M 10-K · filed 2021-02-25 |
| 2018-12-31 | $47.00M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |